Ecully, France

Diedier Festal

This inventor holds 2 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschraenkter Haftung, Merck Patent Gmbh. Active years: 2002-2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Diedier Festal: Innovator in Pharmaceutical Chemistry

Introduction

Diedier Festal is a notable inventor based in Ecully, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cholesteryl acyl transferase (ACAT) inhibitors. His work has led to the filing of multiple patents that showcase his innovative approach to drug development.

Latest Patents

Diedier Festal holds 2 patents related to N-phenylamide and N-pyridylamide derivatives. His latest patents include a method of preparing these compounds and pharmaceutical compositions containing them. The compounds of formula (I) are designed to inhibit ACAT, which plays a crucial role in cholesterol metabolism.

Career Highlights

Throughout his career, Diedier has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug formulation.

Collaborations

Diedier has collaborated with esteemed colleagues such as Guy Augert and Jean Yves Nioche. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Diedier Festal's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…